LauraAnnePetrilloMD
Internal Medicine • Boston, MAHospice & Palliative Medicine
Resident Physician, Internal Medicine, UCSF School of Medicine
Dr. Petrillo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Boston, MA 02114
Education & Training
University of California (San Francisco) School of MedicineFellowship, Hospice and Palliative Medicine, 2015- University of California (San Francisco)Residency, Internal Medicine, 2011 - 2014
- University of California San Francisco School of MedicineClass of 2011
Certifications & Licensure
CA State Medical License 2012 - Present
ME State Medical License Current
MA State Medical License 2017 - 2026
NH State Medical License 2023 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hospice and Palliative Medicine
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Clinical Trials
- Postoperative Pain Control With Fentanyl Patch in Patients Undergoing Mastectomy and TRAM or DIEP Flap Reconstruction Start of enrollment: 2003 Feb 01
Publications & Presentations
PubMed
- 23 citationsTemporal Trends and Outcomes Among Patients Admitted for Immune-Related Adverse Events: A Single-Center Retrospective Cohort Study from 2011 to 2018Gabriel E. Molina, Leyre Zubiri, Justine V. Cohen, Sienna Durbin, Laura A. Petrillo
The Oncologist. 2021-06-01 - 14 citationsEffect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer.Leyre Zubiri, Gabriel E. Molina, Meghan J. Mooradian, Justine V. Cohen, Sienna Durbin
Journal for Immunotherapy of Cancer. 2021-09-01 - 48 citationsPerformance status and end-of-life care among adults with non–small cell lung cancer receiving immune checkpoint inhibitorsLaura A. Petrillo, Areej El-Jawahri, Ryan D. Nipp, Morgan Rl Lichtenstein, Sienna Durbin
Cancer. 2020-05-15
Press Mentions
Immunotherapy May Be Overused in Dying Patients with CancerAugust 8th, 2024- We Asked Readers for Their Thoughts on Medical Aid in Dying. Here’s What They SaidOctober 14th, 2021
Symposia & PodiumsMarch 3rd, 2021- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
